424 related articles for article (PubMed ID: 12928469)
1. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?
Als-Nielsen B; Chen W; Gluud C; Kjaergard LL
JAMA; 2003 Aug; 290(7):921-8. PubMed ID: 12928469
[TBL] [Abstract][Full Text] [Related]
2. The association of funding source on effect size in randomized controlled trials: 2013-2015 - a cross-sectional survey and meta-analysis.
Falk Delgado A; Falk Delgado A
Trials; 2017 Mar; 18(1):125. PubMed ID: 28292317
[TBL] [Abstract][Full Text] [Related]
3. Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials.
Pang WK; Yeter KC; Torralba KD; Spencer HJ; Khan NA
Int J Rheum Dis; 2015 Jul; 18(6):606-15. PubMed ID: 26012523
[TBL] [Abstract][Full Text] [Related]
4. Funding source, trial outcome and reporting quality: are they related? Results of a pilot study.
Clifford TJ; Barrowman NJ; Moher D
BMC Health Serv Res; 2002 Sep; 2(1):18. PubMed ID: 12213183
[TBL] [Abstract][Full Text] [Related]
5. Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005.
Ridker PM; Torres J
JAMA; 2006 May; 295(19):2270-4. PubMed ID: 16705108
[TBL] [Abstract][Full Text] [Related]
6. [Are treatment effects or adverse effects of significance for the association between financing and conclusions in randomized trials?].
Als-Nielsen BE; Chen W; Gluud CN; Gluud LL
Ugeskr Laeger; 2004 Apr; 166(18):1676-8. PubMed ID: 15174406
[No Abstract] [Full Text] [Related]
7. Industry-supported meta-analyses compared with meta-analyses with non-profit or no support: differences in methodological quality and conclusions.
Jørgensen AW; Maric KL; Tendal B; Faurschou A; Gøtzsche PC
BMC Med Res Methodol; 2008 Sep; 8():60. PubMed ID: 18782430
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others.
Bero L; Oostvogel F; Bacchetti P; Lee K
PLoS Med; 2007 Jun; 4(6):e184. PubMed ID: 17550302
[TBL] [Abstract][Full Text] [Related]
9. Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis.
Khan NA; Lombeida JI; Singh M; Spencer HJ; Torralba KD
Arthritis Rheum; 2012 Jul; 64(7):2059-67. PubMed ID: 22275179
[TBL] [Abstract][Full Text] [Related]
10. Differential citation rates of major cardiovascular clinical trials according to source of funding: a survey from 2000 to 2005.
Conen D; Torres J; Ridker PM
Circulation; 2008 Sep; 118(13):1321-7. PubMed ID: 18779441
[TBL] [Abstract][Full Text] [Related]
11. Funding, disease area, and internal validity of hepatobiliary randomized clinical trials.
Kjaergard LL; Gluud C
Am J Gastroenterol; 2002 Nov; 97(11):2708-13. PubMed ID: 12425537
[TBL] [Abstract][Full Text] [Related]
12. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.
Bhandari M; Busse JW; Jackowski D; Montori VM; Schünemann H; Sprague S; Mears D; Schemitsch EH; Heels-Ansdell D; Devereaux PJ
CMAJ; 2004 Feb; 170(4):477-80. PubMed ID: 14970094
[TBL] [Abstract][Full Text] [Related]
13. The association between funding by commercial interests and study outcome in randomized controlled drug trials.
Yaphe J; Edman R; Knishkowy B; Herman J
Fam Pract; 2001 Dec; 18(6):565-8. PubMed ID: 11739337
[TBL] [Abstract][Full Text] [Related]
14. Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials.
Pildal J; Hróbjartsson A; Jørgensen KJ; Hilden J; Altman DG; Gøtzsche PC
Int J Epidemiol; 2007 Aug; 36(4):847-57. PubMed ID: 17517809
[TBL] [Abstract][Full Text] [Related]
15. The uncertainty principle and industry-sponsored research.
Djulbegovic B; Lacevic M; Cantor A; Fields KK; Bennett CL; Adams JR; Kuderer NM; Lyman GH
Lancet; 2000 Aug; 356(9230):635-8. PubMed ID: 10968436
[TBL] [Abstract][Full Text] [Related]
16. Outcome reporting among drug trials registered in ClinicalTrials.gov.
Bourgeois FT; Murthy S; Mandl KD
Ann Intern Med; 2010 Aug; 153(3):158-66. PubMed ID: 20679560
[TBL] [Abstract][Full Text] [Related]
17. Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study.
Dechartres A; Boutron I; Trinquart L; Charles P; Ravaud P
Ann Intern Med; 2011 Jul; 155(1):39-51. PubMed ID: 21727292
[TBL] [Abstract][Full Text] [Related]
18. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.
Roseman M; Milette K; Bero LA; Coyne JC; Lexchin J; Turner EH; Thombs BD
JAMA; 2011 Mar; 305(10):1008-17. PubMed ID: 21386079
[TBL] [Abstract][Full Text] [Related]
19. Self-declared stock ownership and association with positive trial outcome in randomized controlled trials with binary outcomes published in general medical journals: a cross-sectional study.
Falk Delgado A; Falk Delgado A
Trials; 2017 Jul; 18(1):354. PubMed ID: 28747226
[TBL] [Abstract][Full Text] [Related]
20. A meta-epidemiological study to examine the association between bias and treatment effects in neonatal trials.
Bialy L; Vandermeer B; Lacaze-Masmonteil T; Dryden DM; Hartling L
Evid Based Child Health; 2014 Dec; 9(4):1052-9. PubMed ID: 25504975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
